We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microbot Designed to Be Driven Through Blood Vessels

By LabMedica International staff writers
Posted on 25 Jan 2012
Korean scientists are developing microscopic-scale medical robots that represent a new type of therapeutic technology. More...
As anticipated, the microbots, which are less than 1 mm in size, may someday be able to travel throughout the human bloodstream to deliver drugs to specific targets or hunt and destroy tumors, blood clots, and infections that cannot be easily accessed in other ways.

One hurdle in the utilization of microbots, however, is developing a system to effectively “drive’ them and steer them through the complicated and intricate circulatory system, to a defined destination. Researchers from Hanyang University (Seoul, Korea) and Chonnam National University (Gwangju, Korea) described at the American Institute of Physics’ (AIP) Proceedings of the 56th annual conference on Magnetism and Magnetic Materials, held in Scottsdale (AZ, USA), in November 2011, a new navigation system that employed an external magnetic field to generate two distinctive types of microbot movements: helical, which push the microbots forward or backward, or even allow them to “dig” into blood clots or other obstructions; and translational, which allow the ‘bots to, for example, swerve into one side of a branched artery. In laboratory experiments, the researchers used the system to steer accurately a microbot through a mock blood vessel filled with water.

The research, according to the scientists, could be extended to the “precise and effective manipulation of a microbot in several organs of the human body, such as the central nervous system, the urinary system, the eye, and others.”

The study’s findings were part of the Proceedings of the 56th annual conference on Magnetism and Magnetic Materials, planned for publication in the Journal of Applied Physics in April 2012. The research was also published December 16, 2011, in a journal of the American Institute of Physics.

Related Links:
Hanyang University
Chonnam National University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.